Izen Ph. - rezultati pretrage

Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

hizentra

csl behring (nz) ltd - normal immunoglobulin 200 mg/ml; - solution for injection - 20 % - active: normal immunoglobulin 200 mg/ml excipient: hydrochloric acid nitrogen polysorbate 80 proline sodium hydroxide water for injection - replacement therapy in adults and children primary immunodeficiency disease (pid)

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

saizen 8mg click.easy powder and solvent for solution for injection vials

merck serono ltd - somatropin (rmc) - powder and solvent for solution for injection - 8mg

Singapur - engleski - HSA (Health Sciences Authority)

hizentra solution for subcutaneous injection 200gl

csl behring pte. ltd. - human immunoglobulin - injection, solution - human immunoglobulin 200g/l

Australija - engleski - Department of Health (Therapeutic Goods Administration)

hizentra au human normal immunoglobulin 20% solution for subcutaneous injection 50 ml vial

csl behring australia pty ltd - normal immunoglobulin, quantity: 10 g - injection, solution - excipient ingredients: polysorbate 80; proline; water for injections - replacement therapy in adults and children in: - primary immunodeficiency disease (pid) and - symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. immunomodulatory therapy in: - chronic inflammatory demyelinating polyneuropathy (cidp) as maintenance therapy after stabilisation with ivig.